Literature DB >> 31545174

Modeling and optimization of fixed mode dual effect (photocatalysis and photo-Fenton) assisted Metronidazole degradation using ANN coupled with genetic algorithm.

Steffi Talwar1, Anoop Kumar Verma2, Vikas Kumar Sangal3.   

Abstract

The study presents the novel concept of application of fixed bed-batch mode in-situ dual effect of degradation of photo-Fenton and photocatalysis using composite material composed of fuller's earth and foundry sand for the removal of antibiotic Metronidazole. The composite material was involved in the subsequent leaching of iron prompting to in-situ photo-Fenton reactions while TiO2 layer immobilized upon the support involved in photocatalysis. Dual process facilitated the significant reduction in treatment time as 80% of the compound degraded with 30 min of the reaction. Both the processes almost took 180 min for 50% degradation, when applied individually. No doubt, there was an astonishing increase in the rate constant. An artificial neural network model coupled with the genetic algorithm was employed for the optimization of various parameters like H2O2 dose, treatment time, number of beads, pH, etc. Various characterizations have been performed to confirm the novelty of the process. Extended recyclability up to 70 recycles of these composite beads really confirmed the feasibility of this technology for field-scale applications.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ANN-GA; Fixed bed-batch mode; In-situ dual effect; Metronidazole; Recycles; Synergistic effect

Mesh:

Substances:

Year:  2019        PMID: 31545174     DOI: 10.1016/j.jenvman.2019.109428

Source DB:  PubMed          Journal:  J Environ Manage        ISSN: 0301-4797            Impact factor:   6.789


  1 in total

1.  The Clinical Effects of Metronidazole Vaginal Effervescent Tablets Combined with Kushen Suppository in the Treatment of Trichomonas Vaginitis.

Authors:  Hongxia Zhang; Zeng Jing; Feng Li; Benming Yue; Ping Zhang; Hui Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-12       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.